We are live on
!
Find out more
HF
HRT Financial Portfolio holdings
AUM
$40.1B
1-Year Est. Return
58.22%
This Fund
S&P 500
This Quarter
Est. Return
+13.94%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$22.7B
AUM Growth
+$6.91B
(+44%)
Cap. Flow
+$4.55B
Cap. Flow
% of AUM
20.03%
Top 10 Holdings %
Top 10 Hldgs %
42.56%
Holding
3,800
New
1,351
Increased
647
Reduced
509
Closed
1,292
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.95B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$848M |
| 3 |
Applovin
APP
|
+$243M |
| 4 |
AZEK
The AZEK Co
AZEK
|
+$142M |
| 5 |
Thomson Reuters
TRI
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$443M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$430M |
| 3 |
Shopify
SHOP
|
+$320M |
| 4 |
Flutter Entertainment
FLUT
|
+$240M |
| 5 |
Gilead Sciences
GILD
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.27% |
| 2 | Industrials | 7.89% |
| 3 | Technology | 6.89% |
| 4 | Healthcare | 4.69% |
| 5 | Communication Services | 4.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
System1
SST
$17.5M
| $65K | ﹤0.01% |
+11,870
| New | +$52.7K |
|
|
AKYA
2277
DELISTED
Akoya BioSciences
AKYA
| $62K | ﹤0.01% |
+47,706
| New | +$57.4K |
|
2278
Arbe Robotics
ARBE
$94.2M
| $62K | ﹤0.01% |
35,190
+25,055
| +247% | +$35.8K |
|
2279
Century Therapeutics
IPSC
$361M
| $62K | ﹤0.01% |
+111,064
| New | +$59.6K |
|
|
NINE
2280
DELISTED
Nine Energy Service
NINE
| $62K | ﹤0.01% |
81,629
+46,710
| +134% | +$34.3K |
|
2281
W&T Offshore
WTI
$518M
| $62K | ﹤0.01% |
37,911
+21,839
| +136% | +$32.2K |
|
2282
Better Online Solutions
BOSC
$31.2M
| $61K | ﹤0.01% |
+12,719
| New | +$52.1K |
|
2283
Sutro Biopharma
STRO
$421M
| $61K | ﹤0.01% |
8,551
+5,873
| +219% | +$48K |
|
2284
Kyverna Therapeutics
KYTX
$484M
| $61K | ﹤0.01% |
+20,171
| New | +$49.9K |
|
|
CRSH
2285
YieldMax Short TSLA Option Income Strategy ETF
CRSH
$16.1M
| $61K | ﹤0.01% |
+1,291
| New | +$72.9K |
|
|
HFRO
2286
Highland Opportunities and Income Fund
HFRO
$407M
| $60K | ﹤0.01% |
+11,680
| New | +$59K |
|
|
NBP
2287
NovaBridge Biosciences American Depositary Shares
NBP
$202M
| $60K | ﹤0.01% |
25,110
+9,119
| +57% | +$12.4K |
|
2288
Televisa
TV
$1.49B
| $60K | ﹤0.01% |
27,463
+13,533
| +97% | +$26.5K |
|
2289
Zhongchao
ZCMD
$6.65M
| $60K | ﹤0.01% |
+66
| New | +$59.2K |
|
2290
Montauk Renewables
MNTK
$255M
| $58K | ﹤0.01% |
+26,234
| New | +$55.5K |
|
2291
Braskem
BAK
$913M
| $57K | ﹤0.01% |
+17,380
| New | +$63K |
|
|
GCTS
2292
GCT Semiconductor Holding
GCTS
$235M
| $57K | ﹤0.01% |
+38,745
| New | +$52.3K |
|
|
ZJK
2293
ZJK Industrial Co
ZJK
$114M
| $57K | ﹤0.01% |
+14,752
| New | +$65.2K |
|
|
MOB
2294
Mobilicom Ltd
MOB
$74.7M
| $56K | ﹤0.01% |
+22,352
| New | +$43.9K |
|
2295
Outlook Therapeutics
OTLK
$191M
| $56K | ﹤0.01% |
+35,399
| New | +$56.4K |
|
2296
Pyxis Oncology
PYXS
$236M
| $55K | ﹤0.01% |
+50,668
| New | +$57.1K |
|
|
TMDE
2297
TMD Energy Limited
TMDE
$16.9M
| $55K | ﹤0.01% |
+45,869
| New | +$66.5K |
|
2298
Perfect Corp
PERF
$196M
| $54K | ﹤0.01% |
+23,576
| New | +$43.5K |
|
|
ZYXI
2299
DELISTED
Zynex
ZYXI
| $54K | ﹤0.01% |
21,221
+3,764
| +22% | +$8.52K |
|
2300
Cineverse
CNVS
$65.6M
| $53K | ﹤0.01% |
+11,134
| New | +$36.9K |
|
Similar funds
DB
HRT Financial's Q2 2025 Portfolio in Review
As of Q2 2025, HRT Financial held 3,800 positions worth $22.7B, up 44% from $15.8B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
HRT Financial deployed $4.55B of net new capital in Q2 2025, opening 1,351 new positions and adding to 647 existing holdings. Its largest new stake was The AZEK Co: 2,834,659 shares worth $154M.
By sector, the portfolio is most concentrated in Financials at 8.3% of assets, down from 8.3% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $430M trimmed.
- HRT Financial's largest Q2 2025 buy was The AZEK Co: 2,834,659 shares worth $154M.
- HRT Financial added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $1.95B increase.
- HRT Financial's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $430M.
- HRT Financial fully exited Broadcom in Q2 2025, selling an estimated $443M.
- HRT Financial's ten largest holdings make up 43% of its $22.7B portfolio in Q2 2025.
- HRT Financial opened 1,351 new positions and closed 1,292 in Q2 2025.
- HRT Financial's portfolio value rose 44% quarter-over-quarter to $22.7B.
Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.